Covidien appoints Mark Trudeau President of pharmaceuticals segment
pharmafile | January 16, 2012 | Appointment | Business Services, Manufacturing and Production, Sales and Marketing | Covidien
Covidien has announced the appointment of Mark Trudeau as president of its Pharmaceuticals segment and a senior vice president of the company.
Covidien is one of the world’s largest producers of bulk acetaminophen, the largest US supplier of opioid pain medications and among the top 10 generic drug manufacturers in the US.
“Mark has an impressive track record of success in the pharmaceuticals industry, including valuable experience outside the US. We are delighted he is joining Covidien to lead the Pharmaceuticals segment, where he will play a critical role in fulfilling our vision of delivering unmatched value to our customers,” said José Almeida, president and chief executive.
A 25-year pharma industry veteran, Trudeau is president and chief executive officer of Bayer Healthcare, LLC. He also serves as president and chief executive of Bayer Healthcare Pharmaceuticals US Region. Additionally, Trudeau is the lead executive sponsor of Bayer’s women’s leadership initiative and its diversity and inclusion activities. Previously, while serving in these executive roles, he also headed Bayer’s Specialty Medicine Global Business Unit as interim president.
Prior to joining Bayer, Trudeau served as senior vice president and general manager of the Bristol-Myers Squibb Immunology Division. Previous positions at BMS included posts in marketing and assignments leading the company’s regional operations. These posts included regional president, Asia-Pacific, based in Singapore; president, Canadian Operations, headquartered in Montreal; and managing director and general manager, UK Operations, based in London.
Trudeau succeeds Matthew Harbaugh, chief financial officer, Pharmaceuticals, who has served as interim president since November 2010, when former Pharmaceuticals president Timothy Wright resigned. Harbaugh will continue as chief financial officer of the business.
